I-MAK Welcomes Two New Board Members to Champion the Access to Medicines Movement
A Billionaire Pledges to Fight High Drug Prices, and the Industry Is Rattled
Submission to FTC on the Role of Intellectual Property
A Chinese twist in the tale involving Hepatitis C drug Sofosbuvir
Gilead loses key patent claims for Sovaldi in China, opening door to earlier generic entry
Would reforming the U.S. patent system help to lower drug prices?
China Patent Challenge Compels Gilead to Withdraw Key Patent Claims on Sofosbuvir Base Compound, Opening Life-Saving Hepatitis C Treatment Access for Millions
Reality check on PBMs and drug costs
Patent abuse driving high drug prices, non-profit claims
Brainstorm Health: BeiGene IPO, Amerisource CEO on Amazon, California Data Privacy Law